CCL5 and chronic obstructive pulmonary disease: GW3965 (10 μM) reduced the production of CXCL10 and CCL5 from COPD macrophages by 38% and 30% respectively, but these changes did not reach statistical significance (p=0.1 and p=0.2 respectively).